Your Message (required)
I accept that Genoskin collects and processes my personal data. (Required)
I accept to receive Genoskin’s trimestrial newsletter to be informed on the company’s latest developments. I can unsubscribe from this newsletter at anytime. (Required)
Genoskin develops and markets innovative testing tools to study the effects of pharmaceutical, cosmetic and chemical products on real, live ex vivo human skin.
Genoskin to attend BIO Digital 2020 next week
4 June 2020
Genoskin featured in a Business Insider article
16 May 2020
Genoskin selected for round 2 of Mass Challenge Switzerland!
11 May 2020
Genoskin takes part in COVID-19 Virtual Partnering
5 May 2020
COVID-19 update: Genoskin expands R&D capabilities
8 April 2020